274 related articles for article (PubMed ID: 32622891)
1. The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
Syed MN; Shin DB; Wan MT; Winthrop KL; Gelfand JM
J Am Acad Dermatol; 2020 Nov; 83(5):1523-1526. PubMed ID: 32622891
[No Abstract] [Full Text] [Related]
2. The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
Wan MT; Shin DB; Winthrop KL; Gelfand JM
J Am Acad Dermatol; 2020 Aug; 83(2):677-679. PubMed ID: 32416207
[No Abstract] [Full Text] [Related]
3. Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic.
Sanchez DP; Kirsner RS; Lev-Tov H
J Am Acad Dermatol; 2020 Jul; 83(1):288-292. PubMed ID: 32380214
[No Abstract] [Full Text] [Related]
4. Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?
Megna M; Fabbrocini G; Marasca C
Int J Dermatol; 2020 Sep; 59(9):1144-1145. PubMed ID: 32710548
[No Abstract] [Full Text] [Related]
5. Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic.
Kearns DG; Uppal S; Chat VS; Wu JJ
J Am Acad Dermatol; 2020 Sep; 83(3):e251-e252. PubMed ID: 32534081
[No Abstract] [Full Text] [Related]
6. COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy.
Carugno A; Gambini DM; Raponi F; Vezzoli P; Locatelli AGC; Di Mercurio M; Robustelli Test E; Sena P
J Am Acad Dermatol; 2020 Jul; 83(1):292-294. PubMed ID: 32387660
[No Abstract] [Full Text] [Related]
7. Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study.
Georgakopoulos JR; Mufti A; Vender R; Yeung J
J Am Acad Dermatol; 2020 Oct; 83(4):1212-1214. PubMed ID: 32679279
[No Abstract] [Full Text] [Related]
8. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.
Gisondi P; Facheris P; Dapavo P; Piaserico S; Conti A; Naldi L; Cazzaniga S; Malagoli P; Costanzo A
Br J Dermatol; 2020 Aug; 183(2):373-374. PubMed ID: 32343839
[No Abstract] [Full Text] [Related]
9. Remote management of hidradenitis suppurativa in a pandemic era of COVID-19.
Kang NC; Hsiao J; Shi V; Naik HB; Lowes MA; Alavi A
Int J Dermatol; 2020 Sep; 59(9):e318-e320. PubMed ID: 32578210
[No Abstract] [Full Text] [Related]
10. Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts.
Murrell DF; Lucky AW; Salas-Alanis JC; Woodley DT; Palisson F; Natsuga K; Nikolic M; Ramirez-Quizon M; Paller AS; Lara-Corrales I; Barzegar MA; Sprecher E; Has C; Laimer M; Bruckner AL; Bilgic A; Nanda A; Purvis D; Hovnanian A; Murat-Sušić S; Bauer J; Kern JS; Bodemer C; Martin LK; Mellerio J; Kowaleski C; Robertson SJ; Bruckner-Tuderman L; Pope E; Marinkovich MP; Tang JY; Su J; Uitto J; Eichenfield LF; Teng J; Aan Koh MJ; Lee SE; Khuu P; Rishel HI; Sommerlund M; Wiss K; Hsu CK; Chiu TW; Martinez AE
J Am Acad Dermatol; 2020 Oct; 83(4):1222-1224. PubMed ID: 32682031
[TBL] [Abstract][Full Text] [Related]
11. Understanding COVID-19 vaccine efficacy.
Lipsitch M; Dean NE
Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
[No Abstract] [Full Text] [Related]
12. Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations.
Blaszczak A; Trinidad JCL; Cartron AM
J Am Acad Dermatol; 2020 Jul; 83(1):e31. PubMed ID: 32283230
[No Abstract] [Full Text] [Related]
13. Coronavirus reinfections: three questions scientists are asking.
Ledford H
Nature; 2020 Sep; 585(7824):168-169. PubMed ID: 32887957
[No Abstract] [Full Text] [Related]
14. Developing Covid-19 Vaccines at Pandemic Speed.
Lurie N; Saville M; Hatchett R; Halton J
N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
[No Abstract] [Full Text] [Related]
15. Should biologics for psoriasis be interrupted in the era of COVID-19?
Lebwohl M; Rivera-Oyola R; Murrell DF
J Am Acad Dermatol; 2020 May; 82(5):1217-1218. PubMed ID: 32199889
[No Abstract] [Full Text] [Related]
16. Surgery in a Time of Uncertainty: A Need for Universal Respiratory Precautions in the Operating Room.
Livingston EH
JAMA; 2020 Jun; 323(22):2254-2255. PubMed ID: 32379271
[No Abstract] [Full Text] [Related]
17. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
Goudsmit J
Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914
[No Abstract] [Full Text] [Related]
18. China's coronavirus vaccines are leaping ahead - but face challenges as virus wanes.
Cyranoski D
Nature; 2020 Aug; 584(7819):17-18. PubMed ID: 32737453
[No Abstract] [Full Text] [Related]
19. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
20. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(696):1174-1175. PubMed ID: 32496708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
